These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23541423)

  • 1. Cilostazol for the prevention of acute progressing stroke: a multicenter, randomized controlled trial.
    Shimizu H; Tominaga T; Ogawa A; Kayama T; Mizoi K; Saito K; Terayama Y; Ogasawara K; Mori E;
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):449-56. PubMed ID: 23541423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acute medication with cilostazol, an anti-platelet drug, on the outcome of small vessel brain infarction.
    Nakase T; Sasaki M; Suzuki A
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1409-15. PubMed ID: 24513481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
    Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
    Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cilostazol in the treatment of acute ischemic stroke in the lenticulostriate artery territory.
    Kondo R; Matsumoto Y; Furui E; Itabashi R; Sato S; Yazawa Y; Shimizu H; Fujiwara S; Takahashi A; Tominaga T
    Eur Neurol; 2013; 69(2):122-8. PubMed ID: 23207729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
    Shinohara Y; Saito I; Kobayashi S; Uchiyama S
    Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: a pilot study.
    Nakamura T; Tsuruta S; Uchiyama S
    J Neurol Sci; 2012 Feb; 313(1-2):22-6. PubMed ID: 22014645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial.
    Jeng JS; Sun Y; Lee JT; Lin RT; Chen CH; Po HL; Lin HJ; Liu CH; Sun MH; Sun MC; Chern CM; Lien LM; Chiu HC; Hu HH; Chiou HY; Chen ST; Ma H; Hsu CY;
    Int J Stroke; 2015 Jan; 10(1):123-7. PubMed ID: 25394855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
    Shinohara Y; Gotoh F; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Otomo E; Itoh E; Matsuda T; Sawada T; Yamaguchi T; Nishimaru K; Ohashi Y
    Cerebrovasc Dis; 2008; 26(1):63-70. PubMed ID: 18511873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NXY-059 for acute ischemic stroke.
    Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
    N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot Study.
    Ohnuki Y; Ohnuki Y; Kohara S; Shimizu M; Takizawa S
    Intern Med; 2017; 56(11):1307-1313. PubMed ID: 28566591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of the safety of starting administration of low-dose aspirin and cilostazol in acute ischemic stroke.
    Fujita K; Komatsu Y; Sato N; Higuchi O; Kujiraoka Y; Kamezaki T; Suzuki K; Matsumura A
    Neurol Med Chir (Tokyo); 2011; 51(12):819-24. PubMed ID: 22198102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined treatment for acute larger lacunar-type infarction.
    Yamamoto Y; Ohara T; Ishii R; Tanaka E; Murai T; Morii F; Tamura A; Oohara R
    J Stroke Cerebrovasc Dis; 2011; 20(5):387-94. PubMed ID: 20656510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
    Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
    J Am Heart Assoc; 2019 Aug; 8(15):e012652. PubMed ID: 31347430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study.
    Matsumoto M
    Atheroscler Suppl; 2005 Dec; 6(4):33-40. PubMed ID: 16275125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.
    Lee JH; Cha JK; Lee SJ; Ha SW; Kwon SU
    Eur J Neurol; 2010 Mar; 17(3):434-42. PubMed ID: 19922458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis.
    Tan L; Margaret B; Zhang JH; Hu R; Yin Y; Cao L; Feng H; Zhang Y
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):930-8. PubMed ID: 25804574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage.
    Shinohara Y
    Cerebrovasc Dis; 2006; 22(1):57-60. PubMed ID: 16645267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
    Angiolillo DJ; Capranzano P; Goto S; Aslam M; Desai B; Charlton RK; Suzuki Y; Box LC; Shoemaker SB; Zenni MM; Guzman LA; Bass TA
    Eur Heart J; 2008 Sep; 29(18):2202-11. PubMed ID: 18567918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.